AOXG (Aoxing Pharmaceutical Co) Piotroski F-Score: 0 (As of Jul. 03, 2026)


What is Aoxing Pharmaceutical Co Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Aoxing Pharmaceutical Co has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Aoxing Pharmaceutical Co's Piotroski F-Score or its related term are showing as below:

Aoxing Pharmaceutical Co  (OTCPK:AOXG) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Aoxing Pharmaceutical Co Piotroski F-Score Related Terms


Aoxing Pharmaceutical Co Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Aoxing Pharmaceutical Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aoxing Pharmaceutical Co Piotroski F-Score Chart

Aoxing Pharmaceutical Co Annual Data
Trend Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Jun16
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.00 3.00 4.00 7.00 3.00

Aoxing Pharmaceutical Co Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 3.00 3.00 3.00 2.00

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar17) TTM:Last Year (Mar16) TTM:
Net Income was -1.898 + 0.346 + -0.043 + 0.132 = $-1.46 Mil.
Cash Flow from Operations was 1.431 + 0.135 + 0.088 + -3.017 = $-1.36 Mil.
Revenue was 8.825 + 7.569 + 8.009 + 5.702 = $30.11 Mil.
Gross Profit was 6.164 + 6.054 + 6.296 + 4.421 = $22.94 Mil.
Average Total Assets from the begining of this year (Mar16)
to the end of this year (Mar17) was
(58.929 + 56.232 + 58.775 + 58.724 + 62.466) / 5 = $59.0252 Mil.
Total Assets at the begining of this year (Mar16) was $58.93 Mil.
Long-Term Debt & Capital Lease Obligation was $0.10 Mil.
Total Current Assets was $34.80 Mil.
Total Current Liabilities was $43.97 Mil.
Net Income was 4.157 + 1.268 + 2.069 + 0.623 = $8.12 Mil.

Revenue was 7.895 + 8.745 + 8.196 + 6.564 = $31.40 Mil.
Gross Profit was 6.296 + 6.987 + 6.469 + 4.934 = $24.69 Mil.
Average Total Assets from the begining of last year (Mar15)
to the end of last year (Mar16) was
(46.249 + 53.041 + 54.982 + 53.579 + 58.929) / 5 = $53.356 Mil.
Total Assets at the begining of last year (Mar15) was $46.25 Mil.
Long-Term Debt & Capital Lease Obligation was $0.00 Mil.
Total Current Assets was $29.32 Mil.
Total Current Liabilities was $38.03 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Aoxing Pharmaceutical Co's current Net Income (TTM) was -1.46. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Aoxing Pharmaceutical Co's current Cash Flow from Operations (TTM) was -1.36. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar16)
=-1.463/58.929
=-0.02482649

ROA (Last Year)=Net Income/Total Assets (Mar15)
=8.117/46.249
=0.1755065

Aoxing Pharmaceutical Co's return on assets of this year was -0.02482649. Aoxing Pharmaceutical Co's return on assets of last year was 0.1755065. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Aoxing Pharmaceutical Co's current Net Income (TTM) was -1.46. Aoxing Pharmaceutical Co's current Cash Flow from Operations (TTM) was -1.36. ==> -1.36 > -1.46 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar17)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar16 to Mar17
=0.1/59.0252
=0.00169419

Gearing (Last Year: Mar16)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar15 to Mar16
=0/53.356
=0

Aoxing Pharmaceutical Co's gearing of this year was 0.00169419. Aoxing Pharmaceutical Co's gearing of last year was 0. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar17)=Total Current Assets/Total Current Liabilities
=34.803/43.971
=0.79149894

Current Ratio (Last Year: Mar16)=Total Current Assets/Total Current Liabilities
=29.319/38.028
=0.77098454

Aoxing Pharmaceutical Co's current ratio of this year was 0.79149894. Aoxing Pharmaceutical Co's current ratio of last year was 0.77098454. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Aoxing Pharmaceutical Co's number of shares in issue this year was 76.209. Aoxing Pharmaceutical Co's number of shares in issue last year was 75.75. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=22.935/30.105
=0.76183358

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=24.686/31.4
=0.78617834

Aoxing Pharmaceutical Co's gross margin of this year was 0.76183358. Aoxing Pharmaceutical Co's gross margin of last year was 0.78617834. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar16)
=30.105/58.929
=0.51086901

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar15)
=31.4/46.249
=0.6789336

Aoxing Pharmaceutical Co's asset turnover of this year was 0.51086901. Aoxing Pharmaceutical Co's asset turnover of last year was 0.6789336. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+0+1+0+0+0
=2

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Aoxing Pharmaceutical Co has an F-score of 2. It is a bad or low score, which usually implies poor business operation.


Aoxing Pharmaceutical Co Business Description

Address Block 25, Flat F, 9th Floor, South Horizons, Apleichau, Hong Kong, HKG
Aoxing Pharmaceutical Co Inc does not have any business operations and is restructuring for a new business model and plans to acquire an operating company via reverse merger.